# OnCo record dispatch-bio (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/dispatch-bio/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "dispatch-bio" ;
  schema:name "Dispatch Bio"@en ;
  schema:description "Dispatch Bio uses a virus that infects tumour cells and makes them display a marker, so that an existing CAR-T therapy which recognises that marker can then find and kill the cancer. The aim is one approach that works across many solid tumours; its first trial, in advanced bowel, stomach and oesophageal cancers, began dosing in August 2026."@en ;
  schema:url <https://onco.cc/companies/dispatch-bio/>, <https://www.dispatchbio.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.dispatchbio.com/>, <https://www.dispatchbio.com/news/dispatch-bio-launches-to-deliver-universal-treatment-for-solid-tumors-with-novel-immunotherapy-approach/>, <https://www.dispatchbio.com/news/first-patient-dosed-in-phase-1-study-of-disp10/> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/gastric/>, <https://onco.cc/cancers/oesophageal-adenocarcinoma/> ;
  onco:sections <https://onco.cc/fronts/cell-therapy/>, <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/car-t/> ;
  onco:targets <https://onco.cc/targets/bcma/> ;
  onco:companies <https://onco.cc/companies/bms/>, <https://onco.cc/companies/carsgen/> .